GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
2019-08-19 $46.67 $46.84 $45.69 $46.51 230 251
2019-08-16 $45.66 $46.35 $45.62 $46.00 277 129
2019-08-15 $45.41 $45.82 $44.75 $45.02 144 215
2019-08-14 $45.07 $46.19 $44.41 $45.36 273 582
2019-08-13 $44.20 $46.04 $43.69 $45.99 239 391
2019-08-12 $44.33 $45.04 $43.95 $44.32 246 109
2019-08-09 $44.41 $45.16 $43.72 $44.46 266 968
2019-08-08 $43.15 $44.75 $42.90 $44.58 293 860
2019-08-07 $41.36 $42.96 $41.26 $42.80 216 908
2019-08-06 $41.90 $43.40 $40.17 $42.09 390 457
2019-08-05 $43.24 $43.57 $40.96 $41.49 452 095
2019-08-02 $43.50 $44.18 $42.70 $44.04 462 950
2019-08-01 $43.85 $45.19 $43.40 $43.87 373 535
2019-07-31 $43.50 $45.05 $42.83 $43.66 442 333
2019-07-30 $42.74 $43.41 $42.28 $43.29 216 276
2019-07-29 $43.24 $43.24 $41.56 $42.95 204 373
2019-07-26 $41.10 $43.26 $41.00 $43.22 371 254
2019-07-25 $42.49 $42.49 $40.89 $40.96 241 039
2019-07-24 $41.88 $42.65 $41.36 $42.48 192 691
2019-07-23 $42.18 $42.40 $41.54 $42.03 166 162
2019-07-22 $42.24 $42.74 $41.66 $42.00 174 317
2019-07-19 $42.71 $43.37 $40.82 $42.33 309 219
2019-07-18 $41.64 $42.96 $41.64 $42.89 175 072
2019-07-17 $40.96 $41.91 $40.66 $41.74 242 621
2019-07-16 $41.10 $41.70 $40.44 $41.00 199 555
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT